JPMorgan Chase & Co. 13D and 13G filings for Agios Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-10-06 08:37 am Sale |
2022-09-30 | 13G | Agios Pharmaceuticals, Inc. AGIO |
J P MORGAN CHASE & CO JPM |
1,491,001 2.700% |
-1,608,568 (-51.90%) |
Filing |
| 2022-01-19 12:37 pm Purchase |
2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
J P MORGAN CHASE & CO JPM |
3,099,569 5.700% |
3,099,569 (New Position) |
Filing |